US20030129257A1 - Polymer-based material comprising silica particles - Google Patents
Polymer-based material comprising silica particles Download PDFInfo
- Publication number
- US20030129257A1 US20030129257A1 US10/314,448 US31444802A US2003129257A1 US 20030129257 A1 US20030129257 A1 US 20030129257A1 US 31444802 A US31444802 A US 31444802A US 2003129257 A1 US2003129257 A1 US 2003129257A1
- Authority
- US
- United States
- Prior art keywords
- polymer
- based material
- particles
- joint
- sio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *[Si](B)(B)*[2H] Chemical compound *[Si](B)(B)*[2H] 0.000 description 2
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
- A61F2/34—Acetabular cups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30682—Means for preventing migration of particles released by the joint, e.g. wear debris or cement particles
- A61F2002/30685—Means for reducing or preventing the generation of wear particulates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00029—Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00185—Ceramics or ceramic-like structures based on metal oxides
- A61F2310/00203—Ceramics or ceramic-like structures based on metal oxides containing alumina or aluminium oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00185—Ceramics or ceramic-like structures based on metal oxides
- A61F2310/00239—Ceramics or ceramic-like structures based on metal oxides containing zirconia or zirconium oxide ZrO2
Definitions
- a disadvantage of the metal/UHMWPE combination is the static friction which exists between the metal and the plastic, making the plastic part susceptible to wear, and the sensitivity of the UHMWPE to fitting errors and damage during fitting, for example by contamination with bone particles or bone cement.
- the object of the present invention is therefore to provide a polymer-based material and a process for the preparation thereof which at least partially overcomes the disadvantages of the prior art through the material enabling reduced friction between two joint parts in joint implants or artificial joints.
- This object is achieved by a polymer-based material comprising a polyethylene matrix wherein monospherical SiO 2 particles functionalized with non-acidic nucleophiles are distributed in a nanodisperse and homogenous manner.
- Also part of the invention is a process for making a polymer-based material comprising a polyolefin matrix and silica particles as a filling material, said process comprising incorporating said silica particles as early as during the polymerization process, wherein said silica particles are functionalized with non-acidic nucleophiles.
- the invention includes the uses of a polymer-based material for the production of joint implants (for example hip and knee joints) in the medicotechnical area and also the use for the production of sliding bearings, gearwheels and other applications in the industrial sector.
- the present invention furthermore relates to an artificial joint of a prosthesis in which the joint partners consist of metallic, polymeric and/or ceramic materials, with at least one of the joint partners consisting of a polymeric material made from polyolefins with addition of from 1 to 50% by weight of SiO 2 . A range from 5 to 30% by weight of SiO 2 is preferred.
- Suitable polyolefin matrices are all types of polyolefins. However, preference is given to polyethylenes (PE).
- the PE moldings used are preferably UHMWPE moldings, which generally have an extremely high molecular weight of between 3.9 and 10.5 million g/mol.
- Some technically important properties of the polyethylenes such as, for example, wear resistance, notched impact strength, dimensional stability on heating and anti-friction properties, improve with increasing molecular weight.
- the processing properties of the high-molecular-weight PEs are impaired. It is therefore also an object of the invention to be able to use a PE with good processing properties in the composites with similarly good or better properties than with the PEs conventional hitherto.
- silica particles can be loaded, for example, with metallocenes and then employed for the polymerization. It is likewise possible to replace the metallocene loading with a polymerization-active Ziegler-Natta species (for example TiCl 4 ) or Phillips species (for example, chromium oxide immobilized on silica). In this case, the PE forms around the particles, which effects better distribution than subsequent mixing during the extrusion process.
- metallocenes for example TiCl 4
- Phillips species for example, chromium oxide immobilized on silica
- the silica component is present in the polyolefin in an amount of between 1 and 50% by weight of SiO 2 , based on the total weight of the mixture. It should preferably be between 5 and 30% by weight.
- an excessively high SiO 2 content (>55% by weight) has the disadvantage that the material becomes brittle and can fracture.
- Functionalization of the silica particles may be with nucleophilic, non-acidic compounds.
- Representative polyethers include polyethyleneglycol, polypropenyleneoxide, and Poly-THF.
- functionalization may be with polyethers, which enables direct support of methylaluminoxane (MAO)-activatable compounds, principally those of metallocenes (as described in German application DE 10160328.2 and in WO 00/78823).
- the functionalized particles form a gel together with MAO by means of coordinative interactions.
- the metallocene is thus bound to the support via the MAO.
- a homogeneous distribution of support and polymerization-active species is achieved in the process.
- MAO is a cocatalyst that is used to activate metallocenes for olefin polymerization. It generates the polymerization active cationic species from a metallocene.
- the term “catalyst” refers to the activate metallocene-MAO-complex. After drying, the catalyst can be employed directly for the polymerization.
- the polymerization-active compound is applied directly (for example as TiCl 4 vapor) to the silica particles by generally known methods.
- the polymerization is carried out continuously or discontinuously in a known manner in solution, suspension or in the gas phase, with gas-phase and suspension polymerization expressly being preferred.
- Typical temperatures in the polymerization are in the range from 0° C. to 200° C., preferably in the range from 20° C. to 140° C. Further details on the preparation process are given in German application DE 101 60328.2.
- Metallocene loading and catalyst activation are selected in such a way that a catalyst productivity of between 2 and 10 (g of PE)/(g of cat.) is achieved. This corresponds to a silica content of from 10 to 50% by weight.
- Catalysts which are usually employed for polyolefin production and which are designed for high productivities can likewise be used through “dilution” with correspondingly treated silica particles. Preference is given here to the use of olefin-functionalized particles whose surface no longer carries any reactive groups.
- the deactivation is carried out firstly by the olefin functionalization and in addition by treatment with alkylaluminium compounds, for example diisobutylaluminium hydride.
- A is an alkoxy group, preferably ethoxy or methoxy
- B is an alkoxy or alkyl group of the same type, preferably methyl
- D is a hydrocarbon having at least one terminal alkyl or alkenyl function, preferably a linear alkenyl chain having a terminal double bond.
- X is either a direct bond or a heteroatom-containing link, such as (CH 2 ) n —O—, where n is between 1 and 5.
- A is an alkoxy group, preferably ethoxy or methoxy
- B is an alkoxy or alkyl group of the same type, preferably methyl
- C is an alkyl chain having a length of 1-25, preferably 10-20.
- X is either a direct bond or a heteroatom-containing link, such as (CH 2 ) n —O—, where n is between 1 and 5.
- the FIGURE shows a TEM photomicrograph (recorded using a Philips CM20 transmission electron microscope, acceleration voltage 200 kV) of a PE comprising 8% by weight of silica, the sample having been prepared by ultramicrotome technology.
- the material was prepared with the aid of metallocene-loaded silica particles.
- the catalyst productivity was 11 g of polyethylene/g of catalyst. The distribution of the silica particles can clearly be seen.
- the monospheres ( monodisperse SiO 2 particles) functionalized with non-acidic nucleophiles, such as polyether, preferably with PEO, have a diameter of from 10 to 500 nm, preferably about 100 nm.
- the amount of metallocene immobilised on the monospheres is selected in such a way that sufficient polyolefin, preferably UHMWPE, is formed during the polymerization in order to keep the silica content of the product at between 1 and 50% by weight, preferably between 5 and 30% by weight.
- the product exhibits increased abrasion resistance in the ASTM G99 abrasion test compared with conventional PE.
- the mixture is then refluxed for 20 hours.
- the suspension in which the solid is in conglomerated form, is transferred into a beaker.
- the solid is washed five times with deionised water by decantation. After addition of toluene, the water is removed azeotropically from the mixture by means of a water separator.
Abstract
Description
- Artificial joints and joint implants use various materials and material combinations which differ, in particular, in price and durability. Combinations of a suitable metal alloy with ultrahigh-molecular-weight polyethylene (UHMWPE) are amongst the inexpensive approaches which make up the bulk of the implants. These “metal-on-polymer” joint implants are described, for example, in WO 01/17464 (Depuy Int. Ltd.).
- A disadvantage of the metal/UHMWPE combination is the static friction which exists between the metal and the plastic, making the plastic part susceptible to wear, and the sensitivity of the UHMWPE to fitting errors and damage during fitting, for example by contamination with bone particles or bone cement.
- The object of the present invention is therefore to provide a polymer-based material and a process for the preparation thereof which at least partially overcomes the disadvantages of the prior art through the material enabling reduced friction between two joint parts in joint implants or artificial joints.
- This object is achieved by a polymer-based material comprising a polyethylene matrix wherein monospherical SiO2 particles functionalized with non-acidic nucleophiles are distributed in a nanodisperse and homogenous manner.
- Also part of the invention is a process for making a polymer-based material comprising a polyolefin matrix and silica particles as a filling material, said process comprising incorporating said silica particles as early as during the polymerization process, wherein said silica particles are functionalized with non-acidic nucleophiles. Moroever, the invention includes the uses of a polymer-based material for the production of joint implants (for example hip and knee joints) in the medicotechnical area and also the use for the production of sliding bearings, gearwheels and other applications in the industrial sector.
- The present invention furthermore relates to an artificial joint of a prosthesis in which the joint partners consist of metallic, polymeric and/or ceramic materials, with at least one of the joint partners consisting of a polymeric material made from polyolefins with addition of from 1 to 50% by weight of SiO2. A range from 5 to 30% by weight of SiO2 is preferred.
- Suitable polyolefin matrices are all types of polyolefins. However, preference is given to polyethylenes (PE).
- The PE moldings used are preferably UHMWPE moldings, which generally have an extremely high molecular weight of between 3.9 and 10.5 million g/mol. Some technically important properties of the polyethylenes, such as, for example, wear resistance, notched impact strength, dimensional stability on heating and anti-friction properties, improve with increasing molecular weight. At the same time, the processing properties of the high-molecular-weight PEs are impaired. It is therefore also an object of the invention to be able to use a PE with good processing properties in the composites with similarly good or better properties than with the PEs conventional hitherto.
- In prostheses with artificial joints, the requisite compatibility with human or animal tissue, so-called biocompatibility, and the high frictional stress of the joint partners mean that only few materials can be employed. Of the metallic materials, cobalt/chromium/molybdenum (CoCrMo) in particular has proven successful. Applications of titanium-based alloys or surface-modified titanium alloys (for example titanium nitride) are still at the experimental stage. Of the plastics, use is made, in particular, of polyethylene (UHMWPE) in the sockets of hip-joint endoprostheses and as sliding partners of the shinbone component, and aluminium oxide and zirconium oxide are the ceramic materials which can be used.
- Wear within the artificial joint is minimized by the incorporation of hard, non-porous SiO2 beads or silica particles into the PE molding.
- In order to achieve a nanodisperse and extremely homogeneous distribution of the silica particles in the PE, it is advantageous to incorporate them as early as during the polymerization process. UHMWPE is usually not extruded, but instead processed by hot pressing. Subsequent admixing of fillers is not readily possible in this process.
- Various routes (or combinations thereof) can be followed for the incorporation of silica particles into PE during the polymerization process with suitable functionalizations. The silica particles can be loaded, for example, with metallocenes and then employed for the polymerization. It is likewise possible to replace the metallocene loading with a polymerization-active Ziegler-Natta species (for example TiCl4) or Phillips species (for example, chromium oxide immobilized on silica). In this case, the PE forms around the particles, which effects better distribution than subsequent mixing during the extrusion process. It is preferable to select the loading ratio in such a way that the silica component is present in the polyolefin in an amount of between 1 and 50% by weight of SiO2, based on the total weight of the mixture. It should preferably be between 5 and 30% by weight. However, an excessively high SiO2 content (>55% by weight) has the disadvantage that the material becomes brittle and can fracture.
- Functionalization of the silica particles may be with nucleophilic, non-acidic compounds. Such materials include all polyethers with n=1 to 10 and more, also branched ones such as (CH2)n(CH((CH2)mCH3))—O with n<1, and m≦0. Preferred are linear ones with n=2 to 4. Representative polyethers include polyethyleneglycol, polypropenyleneoxide, and Poly-THF. For example, functionalization may be with polyethers, which enables direct support of methylaluminoxane (MAO)-activatable compounds, principally those of metallocenes (as described in German application DE 10160328.2 and in WO 00/78823). The functionalized particles form a gel together with MAO by means of coordinative interactions. The metallocene is thus bound to the support via the MAO. A homogeneous distribution of support and polymerization-active species is achieved in the process. MAO is a cocatalyst that is used to activate metallocenes for olefin polymerization. It generates the polymerization active cationic species from a metallocene. Herein, in this embodiment, the term “catalyst” refers to the activate metallocene-MAO-complex. After drying, the catalyst can be employed directly for the polymerization. In Ziegler-Nafta catalysts (e.g., TiCl4 immobilized on MgCl2), the polymerization-active compound is applied directly (for example as TiCl4 vapor) to the silica particles by generally known methods.
- The polymerization is carried out continuously or discontinuously in a known manner in solution, suspension or in the gas phase, with gas-phase and suspension polymerization expressly being preferred. Typical temperatures in the polymerization are in the range from 0° C. to 200° C., preferably in the range from 20° C. to 140° C. Further details on the preparation process are given in German application DE 101 60328.2.
- Metallocene loading and catalyst activation are selected in such a way that a catalyst productivity of between 2 and 10 (g of PE)/(g of cat.) is achieved. This corresponds to a silica content of from 10 to 50% by weight.
- Catalysts which are usually employed for polyolefin production and which are designed for high productivities can likewise be used through “dilution” with correspondingly treated silica particles. Preference is given here to the use of olefin-functionalized particles whose surface no longer carries any reactive groups. The deactivation is carried out firstly by the olefin functionalization and in addition by treatment with alkylaluminium compounds, for example diisobutylaluminium hydride.
-
- where A is an alkoxy group, preferably ethoxy or methoxy, B is an alkoxy or alkyl group of the same type, preferably methyl, and D is a hydrocarbon having at least one terminal alkyl or alkenyl function, preferably a linear alkenyl chain having a terminal double bond.
- X is either a direct bond or a heteroatom-containing link, such as (CH2)n—O—, where n is between 1 and 5.
-
- where A is an alkoxy group, preferably ethoxy or methoxy, B is an alkoxy or alkyl group of the same type, preferably methyl, and C is an alkyl chain having a length of 1-25, preferably 10-20.
- X is either a direct bond or a heteroatom-containing link, such as (CH2)n—O—, where n is between 1 and 5.
- The following examples and the figure are intended to explain the invention in greater detail.
- The FIGURE shows a TEM photomicrograph (recorded using a Philips CM20 transmission electron microscope, acceleration voltage 200 kV) of a PE comprising 8% by weight of silica, the sample having been prepared by ultramicrotome technology. The material was prepared with the aid of metallocene-loaded silica particles. The catalyst productivity was 11 g of polyethylene/g of catalyst. The distribution of the silica particles can clearly be seen.
- The monospheres (=monodisperse SiO2 particles) functionalized with non-acidic nucleophiles, such as polyether, preferably with PEO, have a diameter of from 10 to 500 nm, preferably about 100 nm. The amount of metallocene immobilised on the monospheres is selected in such a way that sufficient polyolefin, preferably UHMWPE, is formed during the polymerization in order to keep the silica content of the product at between 1 and 50% by weight, preferably between 5 and 30% by weight.
- Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
- In the foregoing and in the following examples, all temperatures are set forth uncorrected in degrees Celsius and, all parts and percentages are by weight, unless otherwise indicated.
- 1. Use as Microparticulate Material for Metallocenes
- 2 g of polyethylene oxide-functionalized monospheres (for preparation, see parallel application “Microparticulate Material” by the applicant with the same application date) having a diameter of 100 nm were stirred for two hours with 4 ml of a solution of methylaluminoxane in toluene (w(MAO)=5%), and 0.2 ml of a solution of dicyclopentadienylzirconium dichloride in the above MAO solution (c(Zr)=0.05 mol/l) was added. After stirring had been continued for a further 30 minutes, the solvent was removed under reduced pressure, leaving a yellow flowing powder which was employed directly for the polymerization (loading: 2.3 μmol of Zr/g of cat., Al/Zr=630).
- For the polymerization, 960 mg of the above catalyst were introduced at 70° C. through a lock by means of an excess pressure of argon into a 1 l steel reactor filled with 400 ml of isobutane and pressurised to 36 bar with ethene. After 10 minutes, the polymerization was terminated by releasing the pressure. Yield: 8.6 g of colourless, flowable powder (productivity: 7.6 g of PE/g of cat., silica content: 11%).
- The product exhibits increased abrasion resistance in the ASTM G99 abrasion test compared with conventional PE.
- 2. Use as Reactor Admixture
- Preparation of C18-silanised Monospheres
- 132 g of monosphere dispersion and 150 g of ethanol are introduced into the 500 ml three-necked flask. The mixture is heated to 70° C., and 12.7 g of ethanolic silane solution are added dropwise over a period of 20 minutes by means of the dropping funnel with vigorous stirring. During the addition, it must be ensured that the solution is introduced at the edge of the vessel, but does not come into contact with its wall.
- The mixture is then refluxed for 20 hours. The suspension, in which the solid is in conglomerated form, is transferred into a beaker. The solid is washed five times with deionised water by decantation. After addition of toluene, the water is removed azeotropically from the mixture by means of a water separator.
- Gravimetric weight determination gives an SiO2 concentration of the dispersion of 19.4% by weight.
- Use as Reactor Admixture
- 10 g of the octadodecyl-functionalized monospheres prepared above in 400 ml of isobutane are introduced into a 1 l steel reactor. The reactor is heated to 70° C. and pressurised to 36 bar with ethene. 80 mg of silica-supported dicyclopentadienylzirconium dichloride are introduced through a lock by means of an excess pressure of argon. After 60 minutes, the reaction is terminated by releasing the pressure.
- Yield: 78 g of colorless granules (0.5-1 mm particle diameter). Catalyst productivity: 850 g of PE/g of catalyst, silica content: 12.8% by weight. The product exhibits increased abrasion resistance in the ASTM G99 abrasion test compared with PE prepared by an identical method without the admixture.
- The entire disclosures of all applications, patents and publications, cited herein and of corresponding German application No. DE 101 60 329.0, filed Dec. 7, 2001 is incorporated by reference herein.
- The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.
- From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention and, without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.
Claims (18)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10160329A DE10160329A1 (en) | 2001-12-07 | 2001-12-07 | Polymer-based material containing silica particles |
DE10160329.0 | 2001-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030129257A1 true US20030129257A1 (en) | 2003-07-10 |
Family
ID=7708498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/314,448 Abandoned US20030129257A1 (en) | 2001-12-07 | 2002-12-09 | Polymer-based material comprising silica particles |
Country Status (4)
Country | Link |
---|---|
US (1) | US20030129257A1 (en) |
EP (1) | EP1318167A3 (en) |
CA (1) | CA2413812A1 (en) |
DE (1) | DE10160329A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080015697A1 (en) * | 2005-06-03 | 2008-01-17 | Nuvasive, Inc. | Prosthetic spinal disc and related methods |
US20080173223A1 (en) * | 2007-01-22 | 2008-07-24 | Nuvasive, Inc. | 3-dimensional embroidery structures via tension shaping |
US20080178786A1 (en) * | 2007-01-31 | 2008-07-31 | Nuvasive, Inc. | Using zigzags to create three-dimensional embroidered structures |
US20080228273A1 (en) * | 2005-07-20 | 2008-09-18 | Mcleod Alan Rory Mor | Implants |
US20080269900A1 (en) * | 2004-05-20 | 2008-10-30 | Christopher Reah | Surgical Implants |
US20080306593A1 (en) * | 2004-03-26 | 2008-12-11 | Mcleod Alan Rory Mor | Prosthetic Spinal Disc |
US20080306595A1 (en) * | 2004-03-26 | 2008-12-11 | Pearsalls Limited | Porous Implant For Spinal Disc Nucleus Replacement |
US20090048677A1 (en) * | 2007-08-13 | 2009-02-19 | Nuvasive, Inc. | Bioresorbable Spinal Implant and Related Methods |
US20100320639A1 (en) * | 2007-02-08 | 2010-12-23 | Christopher Reah | Medical Implants with Pre-Settled Cores and Related Methods |
WO2012087092A1 (en) * | 2010-12-21 | 2012-06-28 | Sigma Alimentos, S. A. De C. V. | Polymeric composition incorporating hollow nanoparticles, method for production thereof and a container produced with the composition |
US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
US20160045318A1 (en) * | 2014-08-13 | 2016-02-18 | Sparkle Medical Llc | Composite prosthetic surfaces |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008020440A1 (en) | 2008-04-23 | 2009-10-29 | Merck Patent Gmbh | Reactive surface-modified particles |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3968313A (en) * | 1971-05-10 | 1976-07-06 | Pearlman Martin B | Surface treatment |
US4017452A (en) * | 1975-04-30 | 1977-04-12 | Presto Products, Incorporated | Polymer modified hydrophilic inorganic fillers for thermoplastic polymeric materials |
US4179537A (en) * | 1978-01-04 | 1979-12-18 | Rykowski John J | Silane coupling agents |
US4187210A (en) * | 1973-12-14 | 1980-02-05 | E. I. Du Pont De Nemours And Company | Homogeneous, highly-filled, polyolefin composites |
US4281070A (en) * | 1980-01-07 | 1981-07-28 | The Polymer Corporation | Melt processable UHMWPE |
US4891392A (en) * | 1987-02-24 | 1990-01-02 | Mitsui Toatsu Chemicals, Incorporated | Production process of polyolefin resin composition containing inorganic filler |
US4972035A (en) * | 1984-02-03 | 1990-11-20 | Mitsui Petrochemical Industries, Ltd. | Process for preparing ultra-high-molecular-weight polyolefin fine powder |
US5017627A (en) * | 1980-10-09 | 1991-05-21 | National Research Development Corporation | Composite material for use in orthopaedics |
US5352732A (en) * | 1990-08-07 | 1994-10-04 | E. I. Du Pont De Nemours And Company | Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof |
US5422386A (en) * | 1993-08-30 | 1995-06-06 | Quantum Chemical Corporation | Process to simultaneously reactor-fill polyolefins and compatibilize fillers with polyolefins |
US5449745A (en) * | 1993-06-01 | 1995-09-12 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
US6444742B1 (en) * | 1998-11-26 | 2002-09-03 | China Petrochemical Corporation | Polyolefin/clay nanocomposites and process for the preparation thereof |
US6524744B1 (en) * | 1998-12-07 | 2003-02-25 | T/J Technologies, Inc. | Multi-phase material and electrodes made therefrom |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2478839B1 (en) * | 1980-03-20 | 1987-07-17 | Bull Sa | POWDER FOR THE DEVELOPMENT OF LATENT IMAGES AND ITS MANUFACTURING METHOD |
EP0049720B1 (en) * | 1980-10-09 | 1986-08-13 | National Research Development Corporation | Prosthesis comprising composite material |
EP0374619A1 (en) * | 1983-11-14 | 1990-06-27 | Idemitsu Kosan Company Limited | Process for the production of polyethylene compositions |
AU665541B2 (en) * | 1991-07-12 | 1996-01-11 | Dentsply International Inc. | Self-lubricating abrasion resistant material and products |
RU2087490C1 (en) * | 1991-07-26 | 1997-08-20 | Е.И.Дюпон Де Немур Энд Компани | Homogeneous composite and method of preparation thereof |
JPH08502093A (en) * | 1992-10-02 | 1996-03-05 | ザ・ダウ・ケミカル・カンパニー | Supported homogeneous catalyst complex for olefin polymerization |
AU8013994A (en) * | 1993-10-15 | 1995-05-04 | Cabot Corporation | Destructured fumed silica for use as a high clarity additive |
WO1997028898A1 (en) * | 1996-02-07 | 1997-08-14 | W.L. Gore & Associates, Inc. | Improved filled porous polymers with surface active agents and methods of making same |
CN1271366A (en) * | 1997-08-29 | 2000-10-25 | 陶氏化学公司 | Homogeneous filled polymer composite |
JP2000051365A (en) * | 1998-08-12 | 2000-02-22 | Hitachi Cable Ltd | Composite catheter tube with ptfe inner laser and its manufacture |
-
2001
- 2001-12-07 DE DE10160329A patent/DE10160329A1/en not_active Withdrawn
-
2002
- 2002-11-07 EP EP02024990A patent/EP1318167A3/en not_active Withdrawn
- 2002-12-05 CA CA002413812A patent/CA2413812A1/en not_active Abandoned
- 2002-12-09 US US10/314,448 patent/US20030129257A1/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3968313A (en) * | 1971-05-10 | 1976-07-06 | Pearlman Martin B | Surface treatment |
US4187210A (en) * | 1973-12-14 | 1980-02-05 | E. I. Du Pont De Nemours And Company | Homogeneous, highly-filled, polyolefin composites |
US4017452A (en) * | 1975-04-30 | 1977-04-12 | Presto Products, Incorporated | Polymer modified hydrophilic inorganic fillers for thermoplastic polymeric materials |
US4179537A (en) * | 1978-01-04 | 1979-12-18 | Rykowski John J | Silane coupling agents |
US4281070A (en) * | 1980-01-07 | 1981-07-28 | The Polymer Corporation | Melt processable UHMWPE |
US5017627A (en) * | 1980-10-09 | 1991-05-21 | National Research Development Corporation | Composite material for use in orthopaedics |
US4972035A (en) * | 1984-02-03 | 1990-11-20 | Mitsui Petrochemical Industries, Ltd. | Process for preparing ultra-high-molecular-weight polyolefin fine powder |
US4891392A (en) * | 1987-02-24 | 1990-01-02 | Mitsui Toatsu Chemicals, Incorporated | Production process of polyolefin resin composition containing inorganic filler |
US5352732A (en) * | 1990-08-07 | 1994-10-04 | E. I. Du Pont De Nemours And Company | Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof |
US5449745A (en) * | 1993-06-01 | 1995-09-12 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
US5422386A (en) * | 1993-08-30 | 1995-06-06 | Quantum Chemical Corporation | Process to simultaneously reactor-fill polyolefins and compatibilize fillers with polyolefins |
US6444742B1 (en) * | 1998-11-26 | 2002-09-03 | China Petrochemical Corporation | Polyolefin/clay nanocomposites and process for the preparation thereof |
US6524744B1 (en) * | 1998-12-07 | 2003-02-25 | T/J Technologies, Inc. | Multi-phase material and electrodes made therefrom |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080306593A1 (en) * | 2004-03-26 | 2008-12-11 | Mcleod Alan Rory Mor | Prosthetic Spinal Disc |
US20080306595A1 (en) * | 2004-03-26 | 2008-12-11 | Pearsalls Limited | Porous Implant For Spinal Disc Nucleus Replacement |
US20110218632A1 (en) * | 2004-05-20 | 2011-09-08 | Nuvasive, Inc. | Surgical implants |
US20080269900A1 (en) * | 2004-05-20 | 2008-10-30 | Christopher Reah | Surgical Implants |
US20090105826A1 (en) * | 2005-06-03 | 2009-04-23 | Mcleod Alan | Surgical Implants |
US20080015697A1 (en) * | 2005-06-03 | 2008-01-17 | Nuvasive, Inc. | Prosthetic spinal disc and related methods |
US20080228273A1 (en) * | 2005-07-20 | 2008-09-18 | Mcleod Alan Rory Mor | Implants |
US20080173223A1 (en) * | 2007-01-22 | 2008-07-24 | Nuvasive, Inc. | 3-dimensional embroidery structures via tension shaping |
US7942104B2 (en) | 2007-01-22 | 2011-05-17 | Nuvasive, Inc. | 3-dimensional embroidery structures via tension shaping |
US7946236B2 (en) | 2007-01-31 | 2011-05-24 | Nuvasive, Inc. | Using zigzags to create three-dimensional embroidered structures |
US20080178786A1 (en) * | 2007-01-31 | 2008-07-31 | Nuvasive, Inc. | Using zigzags to create three-dimensional embroidered structures |
US20100320639A1 (en) * | 2007-02-08 | 2010-12-23 | Christopher Reah | Medical Implants with Pre-Settled Cores and Related Methods |
US20090048677A1 (en) * | 2007-08-13 | 2009-02-19 | Nuvasive, Inc. | Bioresorbable Spinal Implant and Related Methods |
US8282681B2 (en) | 2007-08-13 | 2012-10-09 | Nuvasive, Inc. | Bioresorbable spinal implant and related methods |
US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
WO2012087092A1 (en) * | 2010-12-21 | 2012-06-28 | Sigma Alimentos, S. A. De C. V. | Polymeric composition incorporating hollow nanoparticles, method for production thereof and a container produced with the composition |
US20160045318A1 (en) * | 2014-08-13 | 2016-02-18 | Sparkle Medical Llc | Composite prosthetic surfaces |
US9883946B2 (en) * | 2014-08-13 | 2018-02-06 | Sparkle Medical Llc | Composite prosthetic surfaces |
Also Published As
Publication number | Publication date |
---|---|
EP1318167A2 (en) | 2003-06-11 |
DE10160329A1 (en) | 2003-06-18 |
EP1318167A3 (en) | 2005-02-09 |
CA2413812A1 (en) | 2003-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030129257A1 (en) | Polymer-based material comprising silica particles | |
AU2007211885B2 (en) | Bearing material of medical implant and method for making it | |
US6558428B2 (en) | Precoated polymeric prosthesis and process for making same | |
JP3140780B2 (en) | Ultra high molecular weight polyethylene and its lightly filled composite | |
CN102307945B (en) | Polyethylene materials | |
JP2004524900A (en) | Crosslinked ultra high molecular weight polyethylene used in medical implants | |
JP2006528252A (en) | Injection molding polymer | |
Santavirta et al. | Materials in total joint replacement | |
Puértolas et al. | Improved wear performance of ultra high molecular weight polyethylene coated with hydrogenated diamond like carbon | |
CN115141300A (en) | Ethylene copolymers and articles comprising the same | |
Ferreira et al. | UHMWPE/SBA-15 nanocomposites synthesized by in situ polymerization | |
Catledge et al. | Mesenchymal stem cell adhesion and spreading on nanostructured biomaterials | |
Sprott et al. | Functionalization of PLLA with polymer brushes to trigger the assembly of fibronectin into nanonetworks | |
WO2010027728A1 (en) | Polyethylene polymer composite with pe homopolymer component and pe copolymer component | |
Park et al. | Production of ultrahigh‐molecular‐weight polyethylene/pristine mwcnt composites by half‐titanocene catalysts | |
Puértolas et al. | UHMWPE matrix composites | |
Sharma et al. | Mechanics of ZnO morphological dependence on wear resistance of ultra high molecular weigh polyethylene | |
Liu et al. | Tribological properties of self-reinforced ultra-high molecular weight polyethylene composites | |
JP2021059719A (en) | Ultrahigh molecular weight polyethylene resin and molded body comprising the same | |
DE10324892A1 (en) | Polymer-based material | |
Deb et al. | Effect of crosslinking agents on poly (ethylmethacrylate) bone cements | |
Chen et al. | Clinical applications of uhmwpe in joint implants | |
Wang et al. | Interfacial strength of novel PMMA/HA/nanoclay bone cement | |
Moreno | Carbon reinforced UHMWPE composites for orthopaedic applications: characterization and biological response to wear particles | |
EP0426853B1 (en) | Process for producing thermoplastic elastomer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NIES, BERTHOLD;KOCH, MATTHIAS;WINKLER, HOLGER;REEL/FRAME:013841/0083 Effective date: 20030116 |
|
AS | Assignment |
Owner name: BIOMET DEUTSCHLAND GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MERCK PATENTGESELLSCHAFT MIT BESCHRANKTER HAFTUNG;REEL/FRAME:014797/0110 Effective date: 20040628 Owner name: BIOMET DEUTSCHLAND GMBH,GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MERCK PATENTGESELLSCHAFT MIT BESCHRANKTER HAFTUNG;REEL/FRAME:014797/0110 Effective date: 20040628 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |